Neuromyelitis optica spectrum disorder CT

Jump to navigation Jump to search

Neuromyelitis optica spectrum disorder Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neuromyelitis optica spectrum disorder from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Interventions

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neuromyelitis optica spectrum disorder CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neuromyelitis optica spectrum disorder CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neuromyelitis optica spectrum disorder CT

CDC on Neuromyelitis optica spectrum disorder CT

Neuromyelitis optica spectrum disorder CT in the news

Blogs on Neuromyelitis optica spectrum disorder CT

Directions to Hospitals Treating Neuromyelitis optica spectrum disorder

Risk calculators and risk factors for Neuromyelitis optica spectrum disorder CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Julinka Auta Fernandes

Overview

Computed tomography (CT) is not included as a diagnostic imaging criterion for neuromyelitis optica spectrum disorder (NMOSD) in the cited recommendations. The recommended neurological imaging assessment uses magnetic resonance imaging (MRI) of the brain and spinal cord.[1][2]

Key CT Findings in Neuromyelitis Optica Spectrum Disorder

Brain, Orbital, and Spinal CT

Neuromyelitis optica spectrum disorder has no characteristic diagnostic CT pattern defined in the cited diagnostic recommendations.[1][2]

  • Diagnostic limitations: A normal CT scan does not exclude NMOSD. CT does not fulfil the MRI requirements specified in the diagnostic criteria.[1][2]
  • Optic neuritis: The 2026 consensus statement developed under the Indian Neuro-Ophthalmology Society (INOS) does not recommend CT for diagnosing optic neuritis. This is general optic neuritis guidance relevant to the evaluation of an optic nerve presentation of NMOSD.[3]

Chest CT for Differential Diagnosis

In suspected neuromyelitis optica spectrum disorder, chest CT may help investigate sarcoidosis when neurosarcoidosis is a possible alternative diagnosis.[1][4]

  • When to consider chest CT: The British Thoracic Society (BTS) statement supports thin-section chest CT when suspected sarcoidosis presents with atypical chest radiographic findings, disagreement between clinical and radiographic findings, or diagnostic uncertainty.[4]
  • Potential findings: Thoracic sarcoidosis may show symmetric hilar and mediastinal lymphadenopathy, small pulmonary nodules distributed along lymphatic routes, and fibrosis with distortion of lung architecture.[4]
  • Interpretation: These findings support further assessment for thoracic sarcoidosis. CT may help guide selection of a site for tissue sampling when this is required.[4]
Chest CT showing hilar lymphadenopathy in sarcoidosis, illustrating an alternative diagnosis considered during evaluation of suspected NMOSD.


Image credit: James Heilman, MD, Wikimedia Commons. Licensed under Creative Commons Attribution–ShareAlike 4.0.[5]

References

  1. ↑ 1.0 1.1 1.2 1.3 Jarius S, Aktas O, Ayzenberg I, et al. (2023). "Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis". Journal of Neurology. 270 (7): 3341–3368. doi:10.1007/s00415-023-11634-0. PMC 10267280 Check |pmc= value (help). PMID 37022481 Check |pmid= value (help).
  2. ↑ 2.0 2.1 2.2 Yamout B, Gouider R, Al-Roughani R, et al. (2026). "Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines". CNS Drugs. 40 (3): 283–303. doi:10.1007/s40263-025-01260-x. PMID 41591715 Check |pmid= value (help).
  3. ↑ Phuljhele S, Saxena R, Bhatia R, et al. (2026). "Consensus statement for the diagnosis and management of optic neuritis". Indian Journal of Ophthalmology. 74 (8): 1115–1121. doi:10.4103/IJO.IJO_1634_26. PMC 13485077 Check |pmc= value (help). PMID 42535805 Check |pmid= value (help).
  4. ↑ 4.0 4.1 4.2 4.3 Thillai M, Atkins CP, Crawshaw A, et al. (2021). "BTS Clinical Statement on pulmonary sarcoidosis". Thorax. 76 (1): 4–20. doi:10.1136/thoraxjnl-2019-214348. PMID 33268456 Check |pmid= value (help).
  5. ↑ Heilman, James (2016-05-28). "File:HilarAdenopathyCT.png". Wikimedia Commons. Retrieved 2026-10-29. External link in |title= (help)